← All Sarepta Therapeutics, INC filings

Sarepta Therapeutics, INC Schedule 13D activist filings

Filed when an investor crosses five percent and intends to influence the company — the activist disclosure.

NASDAQ
SRPT
Sarepta Therapeutics, INC
SCHEDULE: Sarepta Divests Entire Stake in Arrowhead Pharma
Sarepta Therapeutics and its investment arm have fully divested their holdings in Arrowhead Pharmaceuticals through a private sale and a share redemption.
NASDAQ
SRPT
Sarepta Therapeutics, INC
SCHEDULE 13D: Sarepta Therapeutics Makes $325 Million Strategic Investment in Arrowhead Pharmaceuticals, Securing Board Seat and Collaboration Rights
Sarepta Therapeutics Investments, a subsidiary of Sarepta Therapeutics, has acquired a 9.5% stake in Arrowhead Pharmaceuticals for $325 million, formalizing a strategic collaboration and gaining board representation.